Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Conley

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Crohn'S & Colitis|September 12, 2020
Prevalence of Covid-19 Symptoms Among Inflammatory Bowel Disease Patients Treated with Biological AgentsThomas E Conley, Chris Probert, Sreedhar Subramanian
Gut|November 19, 2020
Recurrent colonic polypsJoseph Aslan, Thomas E Conley, Fiona Campbell, et al.
European Journal of Gastroenterology & Hepatology|September 28, 2022
Safety and effectiveness of ustekinumab in elderly Crohn's disease patientsJoseph Fiske, Eleanor Liu, Jimmy K Limdi, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2021
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control studyShaji Sebastian, Gareth J Walker, Nicholas A Kennedy, et al.
Alimentary Pharmacology & Therapeutics|May 7, 2021
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort studyChristopher A Lamb, Shaji Sebastian, Alexandra J Kent, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2022
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort studyAamir Saifuddin, Alexandra J Kent, Shameer J Mehta, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Crohn'S & Colitis|September 12, 2020
Prevalence of Covid-19 Symptoms Among Inflammatory Bowel Disease Patients Treated with Biological AgentsThomas E Conley, Chris Probert, Sreedhar Subramanian
Gut|November 19, 2020
Recurrent colonic polypsJoseph Aslan, Thomas E Conley, Fiona Campbell, et al.
European Journal of Gastroenterology & Hepatology|September 28, 2022
Safety and effectiveness of ustekinumab in elderly Crohn's disease patientsJoseph Fiske, Eleanor Liu, Jimmy K Limdi, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2021
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control studyShaji Sebastian, Gareth J Walker, Nicholas A Kennedy, et al.
Alimentary Pharmacology & Therapeutics|May 7, 2021
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort studyChristopher A Lamb, Shaji Sebastian, Alexandra J Kent, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2022
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort studyAamir Saifuddin, Alexandra J Kent, Shameer J Mehta, et al.
Pageof 1